Homepage

Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries

Screening Compounds Building blocks

Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls

Company News & Media Contact us For suppliers Trends in discovery compounds

Homepage > Company > Media > Pharma News > 2018

Pharma News, 2018

$XOSPATA® (gilteritinib) Approved by U.S. FDA for Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) with a FLT3 Mutation$

XOSPATA® (gilteritinib) Approved by U.S. FDA for Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) with a FLT3 Mutation

TOKYO – November 29, 2018 – Astellas Pharma Inc.

Vertex: Two Phase 3 Studies Of VX-659 Triple Combination Met Primary Endpoint

Vertex: Two Phase 3 Studies Of VX-659 Triple Combination Met Primary Endpoint

(RTTNews) - Vertex Pharmaceuticals Inc.

Bayer looks at options for consumer brands, animal health: sources

Bayer looks at options for consumer brands, animal health: sources

FRANKFURT (Reuters) - Bayer (BAYGn.

Novo Nordisk launches type II diabetes awareness campaign

Novo Nordisk launches type II diabetes awareness campaign

Novo Nordisk UK is launching a campaign to raise awareness of the risk of heart attacks and strokes in people living with type II diabetes.

GE Healthcare to open UK biotech manufacturing centre

GE Healthcare to open UK biotech manufacturing centre

GE Healthcare has announced the opening of a biotechnology manufacturing centre at the Stevenage Bioscience Catalyst (SBC) Open Innovation Campus, in Stevenage, UK.

EU court sides with Merck in Endoceutics trademark appeal

EU court sides with Merck in Endoceutics trademark appeal

The EU General Court dismissed Canada-based Endoceutics’ trademark appeal in a win for medical technology company Merck KGaA on Thursday, November 22.

FDA seeks revamp of medical devices approvals

FDA seeks revamp of medical devices approvals

The US Food and Drug Administration (FDA) is set to change the way that medical devices are approved, after 42 years.

Sun Pharma buys Japanese company for $1m

Sun Pharma buys Japanese company for $1m

India-based drug company Sun Pharma has made further inroads into the Japanese market with the planned acquisition of Pola Pharma.

FDA approves an oncology drug that targets a key genetic driver of cancer, rather than a specific type of tumor

FDA approves an oncology drug that targets a key genetic driver of cancer, rather than a specific type of tumor

Generation Z expect ‘technology revolution’ in the NHS

Generation Z expect ‘technology revolution’ in the NHS

New research from Roche UK has revealed that 82% of Generation Z, the age group encompassing 16 to 24 year olds, want to see the NHS introduce digital solutions to better manage their health and i...

Vectura drops severe asthma treatment after poor trial results

Vectura drops severe asthma treatment after poor trial results

(Reuters) - Britain’s Vectura Group Plc will stop developing its treatment for severe uncontrolled asthma after a trial showed it failed to have a significant impact on the condition.

Congo approves clinical trials for Ebola treatments

Congo approves clinical trials for Ebola treatments

KINSHASA (Reuters) - Congolese authorities have authorized clinical trials for four experimental Ebola treatments, which will allow researchers to collect valuable data about their effectivene...

3 4 5 678 9 10 11